This multicentre international clinical study assessed ICU patients at risk of sepsis using on a biomarker-blinded approach. Evaluating for PSP, CRP and CT in the 3 days preceding a sepsis diagnosis, the study considers which proved most accurate in predicting sepsis development. Read more here.
Getz Healthcare is proud to be recognized as the leading distributor of medical equipment, devices and consumables, in Asia Pacific.
Our full-service distribution capabilities provide end-to-end representation of our business partners’ products, while delivering comprehensive service and solutions to our customers in all the countries we serve. Learn more
All product information listed on this site are for healthcare professionals only. Descriptions and specifications of the products listed on this site are provided by the manufacturer.